Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure
- PMID: 28419982
- PMCID: PMC5540738
- DOI: 10.1159/000474958
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure
Abstract
Background: Although high resting heart rate (RHR) is known to be associated with an increased risk of mortality and hospital admission in patients with heart failure, the relationship between RHR and ischemic stroke remains unclear. This study is aimed at investigating the relationship between RHR and ischemic stroke in patients with heart failure in sinus rhythm.
Methods: We examined 2,060 patients with systolic heart failure in sinus rhythm from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. RHR was determined from baseline electrocardiogram, and was examined as both a continuous variable and a categorical variable using quartiles. Ischemic strokes were identified during follow-up and adjudicated by physician review.
Results: During 3.5 ± 1.8 years of follow-up, 77 patients (5.3% from Kaplan-Meier [KM] curve) experienced an ischemic stroke. The highest incidence of ischemic stroke (21/503 [KM 6.9%]) was observed in the lowest RHR quartile (RHR <64 beats/min) compared to other groups; 22/573 (KM 5.3%) in 64-70 beats/min, 13/465 (KM 3.5%) in 71-79 beats/min, and 21/519 (KM 5.4%) in RHR >79 beats/min (p = 0.693). Multivariable Cox proportional hazards analysis revealed that RHR was significantly associated with ischemic stroke (hazard ratio per unit decrease: 1.07, 95% CI 1.02-1.13, when RHR <64/beats/min; p = 0.038), along with a history of stroke or transient ischemic attack and left ventricular ejection fraction.
Conclusions: In contrast to its beneficial effect on mortality and hospital re-admissions, lower RHR may increase the risk of ischemic stroke in patients with systolic heart failure in sinus rhythm.
Keywords: Beta-blocker; Heart failure; Ischemic stroke; Resting heart rate; Sinus rhythm; Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
© 2017 S. Karger AG, Basel.
Figures
Similar articles
-
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7. Circ Heart Fail. 2015. PMID: 25850425 Free PMC article. Clinical Trial.
-
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.Circ Heart Fail. 2013 Sep 1;6(5):988-97. doi: 10.1161/CIRCHEARTFAILURE.113.000372. Epub 2013 Jul 23. Circ Heart Fail. 2013. PMID: 23881846 Free PMC article. Clinical Trial.
-
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.Cerebrovasc Dis. 2013;36(1):74-8. doi: 10.1159/000352058. Epub 2013 Jul 30. Cerebrovasc Dis. 2013. PMID: 23921215 Free PMC article.
-
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.J Am Coll Cardiol. 2017 Jun 20;69(24):2885-2896. doi: 10.1016/j.jacc.2017.04.001. Epub 2017 Apr 30. J Am Coll Cardiol. 2017. PMID: 28467883 Review.
-
Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21. Circ Heart Fail. 2013. PMID: 23264446 Review.
Cited by
-
Age Stratification in Acute Ischemic Stroke Patients with Heart Failure.J Clin Med. 2022 Dec 21;12(1):38. doi: 10.3390/jcm12010038. J Clin Med. 2022. PMID: 36614839 Free PMC article.
-
Dynamic change of heart rate in the acute phase and clinical outcomes after intracerebral hemorrhage: a cohort study.J Intensive Care. 2021 Mar 18;9(1):28. doi: 10.1186/s40560-021-00540-0. J Intensive Care. 2021. PMID: 33736711 Free PMC article.
-
Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post-hoc analysis of the WARCEF trial.Eur J Clin Invest. 2025 Mar;55(3):e14360. doi: 10.1111/eci.14360. Epub 2024 Nov 18. Eur J Clin Invest. 2025. PMID: 39552607 Free PMC article. Clinical Trial.
-
Exploring the Utility of Autonomic Nervous System Evaluation for Stroke Prognosis.Neurol Int. 2023 May 16;15(2):661-696. doi: 10.3390/neurolint15020042. Neurol Int. 2023. PMID: 37218981 Free PMC article. Review.
-
Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation.J Cardiovasc Magn Reson. 2021 Mar 22;23(1):29. doi: 10.1186/s12968-021-00729-0. J Cardiovasc Magn Reson. 2021. PMID: 33745457 Free PMC article.
References
-
- Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation. 2016;133:e38–60. - PubMed
-
- Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65–75. - PubMed
-
- Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L. Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886–894. - PubMed
-
- Li SJ, Sartipy U, Lund LH, Dahlstrom U, Adiels M, Petzold M, Fu M. Prognostic significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: Findings from the Swedish heart failure registry. Circ Heart Fail. 2015;8:871–879. - PubMed
-
- The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial. Lancet. 1999;353:9–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical